Drugmakers Mallinckrodt, Endo in talks to merge, Bloomberg News reports

-0.37%

+0.20% Post

0.00% Post

-0.33%

-0.53%

Dow Jones Industrial Average

DJI

42299.70

-0.37%

ENDO INC

NDOI

25.30

25.50

+0.20%

+0.79% Post

MALLINCKRODT PLC

MCKPF

0.00%

0.00% Post

S&P 500 INDEX

SPX

5693.31

-0.33%

NASDAQ

IXIC

17804.03

-0.53%

March 12 (Reuters) - Mallinckrodt Pharmaceuticals MCKPF.PK and Endo NDOI.PK are exploring a potential merger that could be valued at about $7 billion, Bloomberg News reported on Wednesday, citing people with knowledge of the matter.

(Reporting by Bhanvi Satija in Bengaluru; Editing by Arun Koyyur)

((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.